Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0854720080280020128
Korean Journal of Asthma, Allergy and Clinical Immunology
2008 Volume.28 No. 2 p.128 ~ p.133
The Immunologic Effects of Lactobacillus rhamnosus (Lcr35O Supplements in Adult Patients with Atopic Dermatitis
Lee So-Yeon

Hong Soo-Jong
Kang Mi-Jin
Kim Hyo-Bin
Jang Seong-Ok
Kim Byung-Ju
Yu Jin-Ho
Song Young-Wha
Lee Jung-Yong
Abstract
Background: Probiotics have recently been reported as a means of the prevention and treatment of atopic dermatitis (AD). However, detailed immune mechanisms involved in this effect remain speculative. The aim of this study was to investigate the effects of Lactobacillus rhamnosus (Lcr35) on symptoms of atopic dermatitis and cytokines production in peripheral blood monocytes (PBMCs).

Method: Lcr35 was given to 5 adult patients with mild AD (2 males and 3 females; median SCORAD score, 15.2) for 4 weeks. We examined the SCORAD score and blood samples obtained in the initial, second, fourth and eighth weeks. We observed changes in production of IL-4, IFN-gamma and IL-10 as well as responses to cell proliferation after stimulating PBMCs with Con-A.

Result: There was no relevant significance in the SCORAD score before and after the treatment. PBMC proliferation was inhibited in the second and fourth weeks and was restored 1 month after the cessation of medication. IL-4 was decreased after the medication and persistently decreased after the cessation. IFN-gamma was increased in the second week but decreased in the fourth week. IL-10 was increased in the second week (P=0.008) and showed variant patterns in the fourth week.

Conclusion: The results of this study suggest that Lcr35 supplementation appears to modify cytokine production in PBMCs of AD patients. Further studies are needed to confirm this conclusion.
KEYWORD
AtopicDermatitis, Probiotics, Lactobacillusrhamnosus(Lcr35), IL-10, IL-4
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø